Katalyze builds agentic infrastructure for pharmaceutical operations, helping global pharma companies move medicines from science to patients faster. Its platform combines a source-grounded ontology of pharma operations with expert-designed AI agents trained on knowledge from more than a hundred experienced lab and manufacturing professionals. Designed for regulated environments, the system integrates with existing tools and supports secure, auditable work across pharmaceutical processes.

Katalyze’s solutions include process improvement, technology transfer, deviation management and traceability. AI-powered digital twins help teams identify quality and performance drivers and may lift yield by up to 8%. The platform also carries process understanding between sites, helping receiving teams work to specification, and brings raw-material and process data together to support faster investigations and draft reports. Katalyze says its tools can save up to four hours on investigations.

The company reports that five of the Pharma Top 20 use Katalyze, with customers achieving faster batch release and fewer deviation investigations. Its platform is described as GxP-native, HIPAA compliant and SOC 2 Type II.